Roche CEO Severin Schwan says the offer of $44.50 per share for Illumina is “attractive” and “represents full and fair value.”
Health Blog Video: Roche CEO on the Illumina Bid
Komen Foundation VP resigns after funding controversy
Karen Handel, a vice president with the Susan G. Komen for the Cure Foundation, resigned her position Tuesday following a controversy over funding for Planned Parenthood projects, the foundation said.
How to Avoid Deep-Vein Thrombosis on Long Flights
The guidelines agree with previous studies that first-class and business-class passengers are at risk, too.
Obama to boost Alzheimer’s research funding
The Obama administration will push for a $156 million increase in funding for Alzheimer's research over the next two years, the Department of Health and Human Services announced Tuesday.
Susan G. Komen for the Cure Official Handel Quits
Handel says she thought the decision to end funding to Planned Parenthood because it was the subject of a congressional investigation was the right one.
Health Journal: Deciphering the Ailments Tied to Gluten
A fundamental mystery is why gluten, a staple of most human diets since the dawn of agriculture 10,000 years ago, is creating more health problems now.
A.M. Vitals: Merck Will Apply for Suvorexant Approval This Year
Also: eating on campus; cancer in dogs; Weight Watchers and Points Plus.
Georgia’s child obesity ads aim to create movement out of controversy
Georgia’s controversial child obesity ads are being phased out, but debate continues over whether they do more harm than good.